Sermorelin Food & Supplement Interactions: A Clinical Guide

HealthRX.com

No food or supplement interaction is documented for sermorelin

Print or save as PDF

Key numbers

  • 30 micrograms per kgDose given to children in the pediatric trial, once daily at bedtimeSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 14 daysLength of the twice-daily dosing period in the older-men studySource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 3 hoursTime growth hormone stays raised after an intravenous GHRH dose in healthy menSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • Drug class / GHRH analogue, a 29-amino-acid peptide; not growth hormone [1]
  • Regulatory status / Geref's approvals were withdrawn in 2009; no sermorelin product is FDA-approved today [2]
  • Documented supplement pairing / Arginine with intravenous sermorelin, in diagnostic testing [1]
  • Fasting glucose, 1-year pediatric trial / No change [3]
  • Trial dosing, children / 30 micrograms per kg subcutaneously at bedtime [3]
  • Trial dosing, older men / 0.5 mg or 1 mg twice daily for 14 days [4]
  • Sport status / Prohibited at all times (WADA S2.2.4) [5]

How sermorelin works and how it was dosed in studies

Sermorelin is a 29-amino-acid analogue of human growth hormone-releasing hormone, the shortest synthetic peptide with the full biological activity of GHRH [1]. It acts on the pituitary's GHRH receptor to make the body release its own growth hormone; it is not growth hormone itself [1].

The effect is short-lived. In healthy men given intravenous GHRH(1-29), the peptide was eliminated quickly, yet growth hormone stayed raised for about 3 hours [6]. The 1-year pediatric trial gave a once-daily subcutaneous dose of 30 micrograms per kg at bedtime [3], and a study in older men used twice-daily injections of 0.5 mg or 1 mg for 14 days [4]. Those are the schedules the studies used, not current recommended doses: no sermorelin product is FDA-approved today [2].

What is documented about food and supplement pairings

The studies described on this page did not examine sermorelin with meals, meal timing or macronutrients. With no approved product, there is also no current label listing interactions. Geref was discontinued in 2008, FDA withdrew its two applications in 2009, and sermorelin products sold in the United States today are compounded and not FDA-approved [2][7].

The one supplement link that appears is arginine, and it concerns testing rather than therapy. Adult data indicate that the combination of intravenous sermorelin and arginine is a more specific diagnostic test for growth hormone deficiency, and this merits evaluation in children [1].

Questions worth asking

Choose the questions you want to keep

What the trials recorded about labs and tolerability

In the 1-year pediatric study, 110 previously untreated children with growth hormone deficiency were treated, and 86 were evaluable for efficacy [3]. No adverse changes were seen in general biochemistry or hormone tests, fasting glucose did not change, IGF-I was not excessively raised, and sermorelin was well tolerated overall [3].

In the older-men study, 10 healthy men with a mean age of about 68 received 0.5 mg and 1 mg subcutaneously twice daily for 14 days each, compared with 9 young men [4]. At the high dose, 24-hour growth hormone and IGF-I rose to levels not significantly different from the young men's [4]. It was a short physiology study that measured hormone responses, not a trial of clinical benefit.

Sport testing

Sermorelin is named on WADA's 2026 Prohibited List in S2.2.4 (growth hormone releasing factors), prohibited at all times, in and out of competition [5]. It is also named in the 2027 List [8].

Which supplement has a documented link to sermorelin?
Arginine. Adult data indicate that intravenous sermorelin combined with arginine is a more specific diagnostic test of growth hormone reserve [1]. That finding is about testing, not about boosting a treatment response.
Does sermorelin change blood sugar?
In the 1-year pediatric trial, fasting glucose did not change and there were no adverse changes in general biochemistry or hormone tests [3]. That was in children receiving 30 micrograms per kg daily at bedtime [3].
What doses were used in the studies?
Children received 30 micrograms per kg subcutaneously once daily at bedtime for up to a year [3]. In a separate study, men with a mean age of 68 received 0.5 mg or 1 mg twice daily for 14 days [4]. These are study doses, not current recommendations.
Is there a current sermorelin label listing interactions?
No. Geref was discontinued in 2008 and FDA withdrew its applications in 2009 [2]. Sermorelin sold in the US now is compounded, and compounded drugs are not FDA-reviewed for safety, effectiveness or quality before marketing [7].
Is sermorelin allowed in sport?
No. WADA's 2026 Prohibited List names sermorelin in S2.2.4, prohibited at all times, in and out of competition [5], and the 2027 List names it as well [8].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

What should I not take with sermorelin?

The studies described here document no food or supplement interaction with sermorelin. The only supplement link is arginine, given with intravenous sermorelin as a diagnostic test of growth hormone reserve rather than as a treatment.

What happens if I take sermorelin with food?

Nothing is established. The studies did not examine sermorelin with meals, meal timing or macronutrients, so there is no finding on how food changes its effects. Sermorelin's effect is short-lived: in healthy men given intravenous GHRH(1-29), growth hormone stayed raised for about 3 hours.

Show all 8 referencesHide references
  1. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  2. Federal Register :: Request Access.
  3. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  4. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
  5. World Anti-Doping Agency.
  6. Wilton P, Chardet Y, Danielson K, Widlund L, Gunnarsson R. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10-5.
  7. Official web page.
  8. World Anti-Doping Agency.
Sermorelin food interactions: evidence summary chart
Image: HealthRX.com. Full sermorelin food interactions guide and sources at healthrx.com/sermorelin.